Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma.

Developments in biologicals

Volumn 116, Issue , 2004, Pages

  Morton, D L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; IMMUNOLOGICAL ADJUVANT;

ACTIVE IMMUNIZATION; ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNOLOGY; MELANOMA; METASTASIS; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE;

ADJUVANTS, IMMUNOLOGIC; CANCER VACCINES; COMBINED MODALITY THERAPY; HUMANS; IMMUNOTHERAPY, ACTIVE; MELANOMA; NEOPLASM METASTASIS; POSTOPERATIVE CARE;

EID: 21644443899     PISSN: 14246074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)